Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Reviva Pharmaceuticals Holdings Inc.

    World Rank (Jan-05-2024)
    19,262
    Market Cap (Jan-05-2024)
    0.154 Billion USD
    World Rank (Jul-30-2023)
    21,493
    Market Cap (Jul-30-2023)
    0.104 Billion USD
    World Rank (Dec-25-2022)
    27,510
    Market Cap (Dec-25-2022)
    0.017 Billion USD
    World Rank (Jan-07-2022)
    27,510
    Market Cap (Jan-07-2022)
    0.04 Billion USD
    Headquarters Country
  2. ADC Therapeutics SA

    World Rank (Jan-05-2024)
    19,359
    Market Cap (Jan-05-2024)
    0.152 Billion USD
    World Rank (Jul-30-2023)
    21,504
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    16,329
    Market Cap (Dec-25-2022)
    0.273 Billion USD
    World Rank (Jan-07-2022)
    7,370
    Market Cap (Jan-07-2022)
    1.52 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -246 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    ADC Therapeutics is a Clinical Stage Oncology Biotechnology company, development and commercialization of next generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology. The headquarters is in Switzerland.
    Facts About Company
    ADC Therapeutics company annual revenue was 209 million USD and annual net loss was -155 million USD as on Dec-2022.
  3. Aquestive Therapeutics

    World Rank (Jan-05-2024)
    19,377
    Market Cap (Jan-05-2024)
    0.151 Billion USD
    World Rank (Jul-30-2023)
    21,342
    Market Cap (Jul-30-2023)
    0.107 Billion USD
    World Rank (Dec-25-2022)
    25,206
    Market Cap (Dec-25-2022)
    0.050 Billion USD
    World Rank (Jan-07-2022)
    20,235
    Market Cap (Jan-07-2022)
    0.16 Billion USD
    Annual Revenue in USD
    46 Million USD
    Annual Net Income in USD
    -56 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  4. Actinium Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    19,527
    Market Cap (Jan-05-2024)
    0.146 Billion USD
    World Rank (Jul-30-2023)
    18,494
    Market Cap (Jul-30-2023)
    0.184 Billion USD
    World Rank (Dec-25-2022)
    16,708
    Market Cap (Dec-25-2022)
    0.256 Billion USD
    World Rank (Jan-07-2022)
    21,112
    Market Cap (Jan-07-2022)
    0.14 Billion USD
    Headquarters Country
  5. Abeona Therapeutics

    World Rank (Jan-05-2024)
    19,648
    Market Cap (Jan-05-2024)
    0.143 Billion USD
    World Rank (Jul-30-2023)
    23,014
    Market Cap (Jul-30-2023)
    0.078 Billion USD
    World Rank (Dec-25-2022)
    26,314
    Market Cap (Dec-25-2022)
    0.043 Billion USD
    World Rank (Jan-07-2022)
    26,314
    Market Cap (Jan-07-2022)
    0.05 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Net Income in USD
    -84 Million USD
    Headquarters Country
  6. Design Therapeutics, Inc.

    World Rank (Jan-05-2024)
    19,654
    Market Cap (Jan-05-2024)
    0.143 Billion USD
    World Rank (Jul-30-2023)
    11,986
    World Rank (Dec-25-2022)
    11,986
    Market Cap (Dec-25-2022)
    0.533 Billion USD
    World Rank (Jan-07-2022)
    9,455
    Market Cap (Jan-07-2022)
    1.00 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -35 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Design Therapeutics, INC is a biotechnology company focused on molecules are designed to selectively bind to genetic repeat sequences, modulate gene expression either by restoring or blocking transcription and restore cellular health. The headquarters is in USA.
  7. Vor Biopharma Inc.

    World Rank (Jan-05-2024)
    19,708
    Market Cap (Jan-05-2024)
    0.141 Billion USD
    World Rank (Jul-30-2023)
    18,336
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    12,953
    Market Cap (Dec-25-2022)
    0.460 Billion USD
    World Rank (Jan-07-2022)
    14,870
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Headquarters Country
  8. VistaGen Therapeutics Inc.

    World Rank (Jan-05-2024)
    19,787
    Market Cap (Jan-05-2024)
    0.138 Billion USD
    World Rank (Jul-30-2023)
    30,581
    Market Cap (Jul-30-2023)
    0.014 Billion USD
    World Rank (Dec-25-2022)
    29,346
    Market Cap (Dec-25-2022)
    0.020 Billion USD
    World Rank (Jan-07-2022)
    15,666
    Market Cap (Jan-07-2022)
    0.35 Billion USD
    Headquarters Country
    Company Profile
    VistaGen Therapeutics, Inc. is a Biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders. The company total assets are 108 million USD 2021. The headquarters is in USA.
  9. Relmada Therapeutics

    World Rank (Jan-05-2024)
    19,880
    Market Cap (Jan-05-2024)
    0.136 Billion USD
    World Rank (Jul-30-2023)
    23,042
    Market Cap (Jul-30-2023)
    0.077 Billion USD
    World Rank (Dec-25-2022)
    22,150
    Market Cap (Dec-25-2022)
    0.091 Billion USD
    World Rank (Jan-07-2022)
    12,595
    Market Cap (Jan-07-2022)
    0.58 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -125 Million USD
    Headquarters Country
    Company Profile
    Relmada Therapeutics is a Late Stage Biotech company focused on addressing diseases of the central nervous system (CNS). The headquarters is in USA.
  10. Greenwich LifeSciences Inc.

    World Rank (Jan-05-2024)
    19,932
    Market Cap (Jan-05-2024)
    0.135 Billion USD
    World Rank (Jul-30-2023)
    20,952
    Market Cap (Jul-30-2023)
    0.114 Billion USD
    World Rank (Dec-25-2022)
    18,390
    Market Cap (Dec-25-2022)
    0.187 Billion USD
    World Rank (Jan-07-2022)
    17,015
    Market Cap (Jan-07-2022)
    0.28 Billion USD
    Headquarters Country
    Company Profile
    Greenwich LifeSciences, Inc. is a Public Clinical Stage Biopharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients have previously undergone surgery. The headquarters is in USA.

Share

Ads